DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Gland Pharma Limited — Analysts/Institutional Investor Meet/Con. Call Updates

NSE 3 hrs ago·21 Oct 2026, 11:41 am

Gland Pharma

Gland Pharma has announced the schedule for its upcoming investor meet and conference call. This event is a standard corporate practice where the company management outlines its business strategy and addresses queries from analysts and investors.

For investors, this update is significant as it provides an opportunity to gain clarity on the company's future roadmap. It is a key forum for management to discuss performance metrics, upcoming projects, and address market concerns directly.

Investors should watch for specific details regarding the company's guidance on revenue growth, margin expansion, and any updates on its key product pipelines during the discussion.